UNSPSC 51472804: Chlorhexidine acetate

This classification denotes a topical anti-infective agent with the molecular formula C22H30Cl2N10.2C2H4O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 5908ZUF22Y, chemically known as 1,1'-hexamethylenebis(5-(4-chlorophenyl)biguanide) diacetate, but more generally known as chlorhexidine acetate, which bears US NIH Compound Identifier 9562059. European Medicines Agency schedules chlorhexidine acetate or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06181MIG.

Most nations, for tariff purposes, schedule chlorhexidine acetate under HS 29252900. SMILES: CC(=O)O.CC(=O)O.C1CC(CCC1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC2CCC(CC2)CL)CL.

UNSPSC 51472804 Chlorhexidine acetate is a Commodity code for an antimicrobial chemical used in janitorial, healthcare, and operational cleaning applications across state and local facilities. State and local governments procure this product as part of broader consumable supplies contracts serving fire departments, county operations, healthcare facilities, and state institutions. The issuing bodies soliciting under this code span county purchasing offices, state cooperative purchasing alliances, and special-purpose health authorities, typically bundling chlorhexidine acetate with related janitorial and pharmaceutical supplies in multi-line competitive sealed bid and RFP vehicles.

Hillsborough County Board of County Commissioners issued ITB 26-00319 for janitorial and operational supplies on July 7, 2026, due July 24, 2026, serving the Hillsborough County Fire Rescue Department's 47 fire stations with estimated annual spend of $765,679.84 and delivery to Tampa, Florida. The Minnesota Department of Administration's Office of State Procurement, on behalf of the Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), posted an RFP on January 20, 2026 for generic multi-source pharmaceuticals and OTC products due March 26, 2026, establishing contracts effective July 1, 2026 for participating state and local government facilities including Oregon, with awards to be distributed through three authorized wholesalers (AmerisourceBergen Drug Corporation / Cencora, Cardinal Health, and Morris & Dickson Co., LLC). Geographic activity centers on the Southeast (Florida) and Upper Midwest (Minnesota and Oregon), with cooperative purchasing vehicles enabling multi-jurisdiction access to awarded contracts.